drug
ketamine
Phase 3updated 5mo agoby $NRXP NRX Pharmaceuticals, Inc.
Phase 3community read0 votes
🐶 often sniffed alongside
top 8- drugKETAMINE HYDROCHLORIDE59 co-mentions · 32 sources
- drugKetalar59 co-mentions · 32 sources
- tagApproval58 co-mentions · 29 sources
- tagRecall10 co-mentions · 10 sources
- tagPain4 co-mentions · 1 sources
- drugflumazenil4 co-mentions · 4 sources
- tagOncology2 co-mentions · 1 sources
- tagBreast Cancer2 co-mentions · 1 sources
all catalysts(1)
Trials studying ketamine
- phase3A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- phase3A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- phase4A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression
- —Anesthetics and Analgesics in Children
- phase3Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
- phase1Ketamine Biomarker Validation
- phase4A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment
- phase1Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
News(9)
- How J&J paved the way for Compass’ coming psychedelic drug launchIn an interview with BioPharma Dive, Compass executives said that, should the FDA approve their treatment, they hope to capitalize on a strategy pioneered by J&J in selling the ketamine spray Sprav…biopharma_dive · 13d ago
- As ‘cultural weight’ of a psychedelic approval looms, FDA hearing focuses on access and safetyAs the FDA marches toward the likely first approval of a psychedelic medicine, the agency today convened a hearing seeking public input on how these drugs should be used, monitored and continuously…fiercebiotech · 20d ago
- FDA issues untitled letter to Alar for false advertising of investigational drugThe US Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) has issued an untitled letter to Alar Pharmaceuticals, accusing the company of making misleading claims regard…raps · 1mo ago
- FDA plans to regulate generative AINew clues to RFK Jr.'s vaccine plans, a bottleneck for nurse practitioners, and more health news from Morning Roundsstat · 1mo ago
- Lilly’s $3.8B psychedelics bet won’t open the M&A floodgatesEli Lilly’s $3.8 billion play for AtaiBeckley has fueled speculation that Big Pharma is ready to embrace psychedelics. But while the acquisition does validate the drug class, analysts say it is unl…biospace · 2mo ago
- ‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelicsAfter Eli Lilly dived into the psychedelics space with a $2.8 billion upfront acquisition of AtaiBeckley last week, industry experts told Fierce that the deal would give the space added momentum.fiercebiotech · 2mo ago
- Lilly to buy AtaiBeckley for $2.8B, further validating psychedelicsThe latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical companies may finally be embracing a long-dismissed field of research.biopharma_dive · 2mo ago
- Another big premium hike on the horizonFDA's crackdown on online ketamine retailers, unprecedented health care premium hikes, and more health news from Morning Roundsstat · 2mo ago
- Opinion: The psychedelic revolution is leaving behind people of colorPsychedelics’ potential as a form of treatment is virtually unmatched. But their promise faces both scientific uncertainty and thorny political questions.stat · 5mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that